does glp 1 not work for some people The GLP-1 revolution: What UAB researchers are discovering about how these drugs Why Dieting Feels Different on

The objective was to evaluate the effectiveness and safety, with a specific focus on cardiovascular safety, of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, compared to insulin glargine in adults with type 2 diabetes and a high risk of cardiovascular events who have not achieved adequate control with oral glucose-lowering medications.This phase 3 study was conducted at 187 sites across 14 countries on five continents

This is the landscape were in right now

(Supplementary Clinical Sequelae 1)

Med Sci Sports Exerc 40(1):8895 Sartori R, Romanello V, Sandri M (2021) Mechanisms of muscle atrophy and hypertrophy: implications in health and disease